MINDCURE makes a CAD$500,000 strategic investment in ATMA Journey Centers, an Alberta-based psychedelics-assisted mental health clinic.
Psychedelics
First-of-its-kind trial finds psychedelic microdosing is equal to placebo
A first of its kind "self-blinded" trial testing the effect of psychedelic microdosing has found the anecdotally popular practice may be an example of a strong placebo effect.
Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter
Novamind reports rising revenues and cash on hand of CAD$10 million.
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain
Mydecine exports dried psilocybin mushrooms from Jamaica to Canada.
What Field Trip’s Huge Financing Tells Investors
Field Trip Health just announced the 3rd largest financing by a psychedelics public company: a CAD$82.875 million bought deal. Here's what it means for investors.
Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering
With its (upsized) $82.875 million dollar financing, Field Trip establishes itself as one of the industry leaders in the psychedelics space.
Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
Optimi Health has commenced public trading (symbol "OPTI"). The Company raised CAD$20.7 million for its IPO financing.
Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil
TRIP gains access to the huge Brazilian market for its psilocybin truffles.
PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange
PsyBio has commenced trading. Its focus is on drug development for the Mental Health Crisis.
Study: Psychedelics and Music Together Could Treat Addiction
Psychedelic therapy has been gaining not only popularity but acceptance in the medical community in recent years.
Psychedelic Drug Stocks Then-And-Now: Six Months Ago Versus Today
Psychedelic stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
Microneedle patches for microdosing psychedelic pharmaceuticals
Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use.
NYU launching $10M Center for Psychedelic Medicine in Manhattan
New York University wants to expand our minds — but in a trippy new way.
Massachusetts Moves Forward In Decriminalizing Psychedelics
Massachusetts lawmakers are moving forward to decriminalize psychedelic drugs. T
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
MINDCURE's new Director is a veteran of capital markets.